EARS News and Press, Auris Medical Holding AG From 01/29/21

Hamilton, Bermuda, January 29, 2021 – Auris Medical Holding Ltd. (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology, rhinology and allergy and CNS disorders, today announced with its affiliate Altami...

Unique Pipelines Could Have These Penny Stocks On The Radar Before 2021 We talked about some biotech penny stocks earlier today and several took flight early. As the markets race to all-time highs once again, it’s no wonder why this sector is on fire. Countless companies are ...

Hamilton, Bermuda, December 7, 2020 – Auris Medical Holding Ltd. (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology, rhinology and allergy and CNS disorders, today announced that Chairman and CEO Tho...

Gainers: Obalon Therapeutics (OBLN) +116%, Oncternal Therapeutics (ONCT) +77%, Fate Therapeutics (FATE) +41%, Constellation Pharmaceuticals (CNST) +33%, Nkarta (NKTX) +28%.Losers: scPharmaceuticals (SCPH) -33%, Aptose Biosciences (APTO) -...

Listen on the go! A daily podcast of Wall Street Breakfast's Alpha Talks will be available this morning on Seeking Alpha, iTunes, Stitcher and Spotify. All three major stock market indexes closed at all-time highs Friday as D.C. lawmakers appeared to make progress toward passing a COVID stimu...

Gainers: NanoVibronix (NAOV) +99%.Merrimack Pharmaceuticals (MACK) +46%.Catabasis Pharmaceuticals (CATB) +44%.Tredegar (TG) +27%.Intec Pharma (NTEC) +27%.Kingsway Financial Services (KFS) +25%.Sequential Brands (SQBG) +23%.Sequans Communications (SQNS) +20%.Mmtec (MTC) +20%.Callon Petrol...

Gainers: Catabasis Pharmaceuticals (CATB) +44%, iBio (IBIO) +21%, Cellectar Biosciences (CLRB) +21%, Intec Pharma (NTEC) +18%, Sio Gene Therapies (SIOX) +18%.Losers: Ovid Therapeutics (OVID) -55%, Auris Medical (EARS) -35%, iRhythm Techno...

Auris Medical Holding (EARS) is down 21.61% premarket after the pricing of 2M common shares direct offering at-the-market price of $4/share, compared to the yesterday's spike closing at $5.23.The company intends to use the net proceeds for working capital and general corporate purpo...

Ovid Therapeutics (OVID) -51% after it misses goal in Angelman syndrome treatment.FuelCell Energy (FCEL) -25% after discloses below-consensus FQ4 revenues; to launch offering.Workhorse Group (WKHS) -22% after Trucks.com reports of further delays in the ...

Hamilton, Bermuda, December 2, 2020 – Auris Medical Holding Ltd. (NASDAQ: EARS) (“Auris” or the “Company”), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology, rhinology and allergy and C...